SPP1 and cancer: As was shown in the study by Zhou et al (26), the restoration of the DLC1 protein in the cancer cell lines, which were previously devoid of DLC1, reduces the expression of mRNA for osteopontin, which indicates that DLC1 possesses the ability to negatively regulate osteopontin.